Startups
Pulmobiotics SL is a a spin off company from the Centre for Genomic Regulation (Barcelona - Spain) founded by experienced entrepreneurs and funded by invivo Ventures. Using a proprietary microbial engineering and synthetic biology toolbox our founders have created a platform based on attenuated lung bacteria that is able to expose antigens or deliver therapeutic agents in the lung in a controlled, local and continuous manner. Pulmobiotics SL will use this technology to discover and develop novel treatments and vaccines for respiratory diseases, which are among the most common causes of severe illness and death worldwide.
Overview
Location
Spain, Catalonia, Barcelona
Employees
1-10
Total raised
$2M
Founded date
2020
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jan 24, 2024 | Who are Catalonia’s Most Influential Game-Changers in Biotech, 2023? | The biotechnology scene in Catalonia, Spain, is thriving, with many innovative start-ups to its credit. Each of these companies is working towards the monumental task of pushing the boundaries of science to shape the future of healthcare, l... |
| Dec 15, 2022 | Pulmobiotics, participada por Invivo, recibe €1,9M para desarrollar una píldora viva para el cáncer de pulmón | 15/12/2022 Nota de prensa PULMOBIOTICS, PARTICIPADA POR INVIVO, RECIBE €1,9M PARA DESARROLLAR UNA PÍLDORA VIVA PARA EL CÁNCER DE PULMÓN El equipo científico de Pulmobiotics, una empresa fundada en 2020 en el Centro de Regulación Genómica... |
Reviews 0
FAQ about Pulmobiotics SL
When was Pulmobiotics SL founded?
Pulmobiotics SL was founded in 2020.
How much funding has Pulmobiotics SL raised?
Pulmobiotics SL has raised $2M in total across 1 funding round.
What has the press written about Pulmobiotics SL?
Parsers VC has collected 3 articles mentioning Pulmobiotics SL, among them “Who are Catalonia’s Most Influential Game-Changers in Biotech, 2023?” (Jan 24, 2024) and “Pulmobiotics, participada por Invivo, recibe €1,9M para desarrollar una píldora viva para el cáncer de pulmón” (Dec 15, 2022).
Is Pulmobiotics SL still active?
Pulmobiotics SL is probably closed: its latest activity on Parsers VC dates from Mar 6, 2024.